KUALA LUMPUR, May 6 -- Biotalys NV, a transformative food and crop protection company, has announced the results from over 100 field trials with its first, breakthrough biofungicide, BioFun-1.
According to a statement by the Belgium-based company, BioFun-1 is on track to be launched in the United States (US) in 2022, followed by global market introductions.
Developing a new generation of protein-based biocontrol solutions, Biotalys aims to help farmers protect yields and reduce food waste by both preventing crop loss and extending post-harvest protection with sustainable and safe products.
The 2019 field trial programme took place across the US and key European countries and included more than 50 efficacy trials against major pests such as Botrytis cinerea and powdery mildew.
These diseases considerably impact yields and quality in a wide range of fruit and vegetable crops, and are responsible for significant food losses, pre- and post-harvest.
In solo applications, BioFun-1 has provided high protection against multiple pathogens in the majority (over 85 per cent) of the trials compared to the untreated control.
BioFun-1 showed a clean dose response curve, allowing dose rate modulation to adapt to the disease pressure conditions. Under severe disease pressure, a higher dose rate provides comparable protection to the chemical reference without the challenge of residues for the growers.
The next field trial programme is already in process, spanning more than 150 field trials in various crops and different environmental conditions in Europe, South Africa and the US.
The 2020 field trial programme will support the regulatory efficacy data package and focus on the intrinsic activity of the biofungicide, field efficacy validation and characterisation, and the impact of the end-season positioning in harvested fruits and vegetables.
-- BERNAMA
No comments:
Post a Comment